πŸ‡ΊπŸ‡Έ FDA
Patent

US 7417165

Crystalline forms of pregabalin

granted A61PA61P25/22

Quick answer

US patent 7417165 (Crystalline forms of pregabalin) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Aug 26 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P25/22